Richard C. Edel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Richard C. Edel has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Amy M. Dorward
School of Medicine University of St Andrews St Andrews UK
1 shared publicationChloe L. O'ROurke
School of Medicine University of St Andrews St Andrews UK
1 shared publicationClaire Sneddon
School of Medicine University of Dundee Dundee UK
1 shared publicationColin E. Murdoch
School of Medicine University of Dundee Dundee UK
1 shared publication- Daiki Watanabe
Osaka University of Health and Sport Sciences
1 shared publication David J. Harrison
School of Medicine University of St Andrews St Andrews UK
1 shared publication
Latest Publications
- Open Access
- 22 January 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (2) , e71440
Knockout of the Intracellular Calcium Conducting Ion Channel Mitsugumin 23 ( MG23 ) Protects Against Pressure Overload Induced Left Ventricular Hypertrophy and Cardiac Dysfunction
In cardiac dysfunction, intracellular Ca 2+ ‐dynamics are disrupted leading to leakage of Ca 2+ from the sarcoplasmic reticulum (SR). This results in diminished cardiac contractility and impaired cardiac function. In cardiac tissue, the underlying molecular mechanisms responsible for RyR2‐independent Ca 2+ ‐leak are poorly understood. Mitsugumin 23 (MG23) is an intracellular Ca 2+ ‐conducting ion channel located on endoplasmic/sarcoplasmic reticulum (ER/SR) and nuclear membranes. We propose that MG23 contributes to regulation of intracellular Ca 2+ ‐homeostasis, and that altered MG23 function may drive progression of cardiac dysfunction. The aim of this research was to investigate the role of MG23 in SR Ca 2+ ‐leak, and whether knockout of Mg23 protects the heart against pressure‐overload induced left ventricular hypertrophy. Cardiac pressure‐overload was induced in wild type (WT) and Mg23 ‐knockout (KO) mice through subcutaneous Angiotensin II (AngII, 1.1 mg/kg/day) infusion via osmotic pump. After 10‐day infusion, in vivo pressure‐volume dynamics were measured by insertion of a pressure‐volume catheter into the left ventricle. MG23 protein expression was assessed through Western blot analysis. Ventricular fibrosis and cardiomyocyte size were measured using histological and immunofluorescence approaches. Cardiomyocytes were isolated from WT and Mg23 ‐KO hearts and intracellular Ca 2+ ‐dynamics assessed through live cell imaging using the Ca 2+ indicator Fluo‐4. AngII‐induced cardiac pressure‐overload increased expression of MG23 in WT mouse hearts. Knockout of Mg23 protected hearts against AngII‐induced cardiac hypertrophy. Compared to WT animals, AngII treated Mg23 ‐KO mice displayed a significant reduction in left ventricular fibrosis and displayed normal cardiac functioning. Overexpression of MG23 in the ventricular cell line H9C2, resulted in reduced SR Ca 2+ store levels. In Mg23‐ KO hearts, no alteration in expression of key Ca 2+ ‐handling proteins was identified, but cardiomyocytes displayed altered Ca 2+ ‐spark profiles consistent with a role for MG23 in SR Ca 2+ ‐leak. MG23 plays a key role in driving Ca 2+ ‐dysregulation observed in the early pathological stages of pressure‐overload induced heart failure.
- 22 January 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (2) , e71440
Open AccessKnockout of the Intracellular Calcium Conducting Ion Channel Mitsugumin 23 ( MG23 ) Protects Against Pressure Overload Induced Left Ventricular Hypertrophy and Cardiac Dysfunction
In cardiac dysfunction, intracellular Ca 2+ ‐dynamics are disrupted leading to leakage of Ca 2+ from the sarcoplasmic reticulum (SR). This results in diminished cardiac contractility and impaired cardiac function. In cardiac tissue, the underlying molecular mechanisms responsible for RyR2‐independent Ca 2+ ‐leak are poorly understood. Mitsugumin 23 (MG23) is an intracellular Ca 2+ ‐conducting ion channel located on endoplasmic/sarcoplasmic reticulum (ER/SR) and nuclear membranes. We propose that MG23 contributes to regulation of intracellular Ca 2+ ‐homeostasis, and that altered MG23 function may drive progression of cardiac dysfunction. The aim of this research was to investigate the role of MG23 in SR Ca 2+ ‐leak, and whether knockout of Mg23 protects the heart against pressure‐overload induced left ventricular hypertrophy. Cardiac pressure‐overload was induced in wild type (WT) and Mg23 ‐knockout (KO) mice through subcutaneous Angiotensin II (AngII, 1.1 mg/kg/day) infusion via osmotic pump. After 10‐day infusion, in vivo pressure‐volume dynamics were measured by insertion of a pressure‐volume catheter into the left ventricle. MG23 protein expression was assessed through Western blot analysis. Ventricular fibrosis and cardiomyocyte size were measured using histological and immunofluorescence approaches. Cardiomyocytes were isolated from WT and Mg23 ‐KO hearts and intracellular Ca 2+ ‐dynamics assessed through live cell imaging using the Ca 2+ indicator Fluo‐4. AngII‐induced cardiac pressure‐overload increased expression of MG23 in WT mouse hearts. Knockout of Mg23 protected hearts against AngII‐induced cardiac hypertrophy. Compared to WT animals, AngII treated Mg23 ‐KO mice displayed a significant reduction in left ventricular fibrosis and displayed normal cardiac functioning. Overexpression of MG23 in the ventricular cell line H9C2, resulted in reduced SR Ca 2+ store levels. In Mg23‐ KO hearts, no alteration in expression of key Ca 2+ ‐handling proteins was identified, but cardiomyocytes displayed altered Ca 2+ ‐spark profiles consistent with a role for MG23 in SR Ca 2+ ‐leak. MG23 plays a key role in driving Ca 2+ ‐dysregulation observed in the early pathological stages of pressure‐overload induced heart failure.
- Open Access
Predicted Role of Mitsugumin 23 in Skeletal and Cardiac Muscle
Mitsugumin 23 (MG23) is a transmembrane protein expressed in the nuclear membrane and endo/sarcoplasmic reticulum (ER/SR) of various tissues, including skeletal and cardiac muscle. MG23 is a non-selective cation channel that has been implicated in the leakage of calcium ions (Ca2+) under diverse pathophysiological conditions. SR Ca2+ leak is considered to be a contributing factor of skeletal muscle weakness and is also implicated in the progression of heart failure. The absence of MG23 has been reported to alleviate negative outcomes associated with SR Ca2+ leak. Targeting MG23 could represent a new therapeutic strategy against muscle disorders. This review discusses the potential role of MG23 in skeletal and cardiac muscle, and highlights MG23 as both a regulator of basal SR Ca2+-handling and a mediator of pathophysiological remodelling in muscle.
Open AccessPredicted Role of Mitsugumin 23 in Skeletal and Cardiac Muscle
Mitsugumin 23 (MG23) is a transmembrane protein expressed in the nuclear membrane and endo/sarcoplasmic reticulum (ER/SR) of various tissues, including skeletal and cardiac muscle. MG23 is a non-selective cation channel that has been implicated in the leakage of calcium ions (Ca2+) under diverse pathophysiological conditions. SR Ca2+ leak is considered to be a contributing factor of skeletal muscle weakness and is also implicated in the progression of heart failure. The absence of MG23 has been reported to alleviate negative outcomes associated with SR Ca2+ leak. Targeting MG23 could represent a new therapeutic strategy against muscle disorders. This review discusses the potential role of MG23 in skeletal and cardiac muscle, and highlights MG23 as both a regulator of basal SR Ca2+-handling and a mediator of pathophysiological remodelling in muscle.